Bethany Cook
Women's Health · Oklahoma City, OKNPI 1891702759
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.1% of the total across 112 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 12.8% — the pattern of someone who eats at a lot of different presentations. Among women's health clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 112 payments — averaging $25.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$361
- Novo Nordisk$323
- Daiichi Sankyo Inc.$272
- Globus Medical$238
- Bayer$215
- Mayne Pharma Commercial LLC$178
- plus $1K from 32 others
What the payments were for
- Travel & lodging$1094%
- Food & beverage$2,71296%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 3 | $361 |
| Novo Nordisk | 17 | $323 |
| Daiichi Sankyo Inc. | 8 | $272 |
| Globus Medical | 2 | $238 |
| Bayer | 13 | $215 |
| Mayne Pharma Commercial LLC | 7 | $178 |
| Astellas Pharma US Inc | 9 | $162 |
| AstraZeneca | 1 | $125 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $79 |
| Organon | 5 | $73 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $48 |
| Amgen | 3 | $39 |
| Avion Pharmaceuticals | 2 | $37 |
| Lundbeck LLC | 2 | $36 |
| Millicent US Inc | 2 | $34 |
| AbbVie(2 entities) | 2 | $34 |
| Pfizer | 2 | $32 |
| Corcept Therapeutics | 2 | $30 |
| Nalu Medical, Inc. | 1 | $30 |
| Scynexis, Inc. | 2 | $30 |
| Exeltis, USA Inc. | 2 | $30 |
| Mylan Pharmaceuticals Inc. | 2 | $28 |
| Averitas Pharma Inc. | 1 | $28 |
| Merck | 2 | $27 |
| Antares Pharma, Inc. | 2 | $25 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Johnson & Johnson | 1 | $21 |
| Medtronic | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Minerva Surgical, Inc | 1 | $19 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Ardelyx, Inc. | 1 | $14 |
| Myovant Sciences Inc. | 1 | $14 |
| GSK | 1 | $13 |
| Channel Medsystems, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$361
- Senza$143
- ANDEXXA$125
- INJECTAFER$125
- TOUJEO$100
How this compares
$2,821 in reported general payments places this provider in the 90th percentile of 62 women's health providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 11 | $365 |
| Levothyroxine Sodium | 18 | $168 |
Paid to pharmacies, not to this prescriber.
Other women's health in Oklahoma City
- Hilary MillerOklahoma City$38K
- Beverly CotnerOklahoma City$4K
- Whitney HunterOklahoma City$3K
- Erika RumbleOklahoma City$2K
- Jaclyn ShaverOklahoma City$2K
- Meredith DewitteOklahoma City$2K
- Charnelle DeanOklahoma City$711
- Joyce TowOklahoma City$507
- Maria MeyerOklahoma City$378
- Amanda KenneyOklahoma City$343
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.